Cochrane Evidence Synthesis and Methods ►

Fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG-PET/CT) for detecting metastases of Ewing sarcoma

To determine the accuracy of ¹⁸F-FDG-PET/CT imaging for detection of metastases of Ewing sarcoma (lymph node, bone, bone marrow or lung) at first diagnosis.

This is a protocol.

Health topics:

Cancer > Soft tissue sarcoma

Child health > Cancer > Sarcoma

Published:

12 April 2016

Authors:

Haveman LM, Breunis WB, Cohen JF, van Dalen EC, Owers EC, Dirksen U, Kremer LCM, Jürgens H, van den Berg H, Merks JHM

See the full Review on

the Cochrane Library

►

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Haveman LM, Breunis WB, Cohen JF, van Dalen EC, Owers EC, Dirksen U, Kremer LCM, Jürgens H, van den Berg H, Merks JHM. Fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG-PET/CT) for detecting metastases of Ewing sarcoma. Cochrane Database of Systematic Reviews 2016, Issue 4. Art. No.: CD012133. DOI: 10.1002/14651858.CD012133